FDA May Request "Intermediate" Enforcement Authority For Clinical Trials

FDA is considering asking Congress for authority to bring intermediate enforcement actions in response to violations of human research regulations in clinical trials, FDA Office of Regulatory Affairs Director of Enforcement Daniel Michels told the House Government Reform/Human Resources Subcommittee May 3.